TABLE 4.
Comparing Options for Management: Patient-centered Results for Uterine Fibroids (COMPARE-UF) enrollment to date by procedure and age
| Procedure | Age, n | |||||||
|---|---|---|---|---|---|---|---|---|
| 18–24 Y | 25–29 Y | 30–34 Y | 35–40 Y | 41–45 Y | 46–50 Y | ≥51 Y | Unknown | |
| Hysterectomy (n=764; 38%) | 1 | 3 | 17 | 115 | 238 | 289 | 101 | 14 |
| Myomectomy-abdominal (n=280; 14%) | 3 | 16 | 80 | 99 | 50 | 28 | 4 | 5 |
| Myomectomy-laparoscopic/robotic (n=386; 19%) | 4 | 31 | 84 | 152 | 78 | 29 | 8 | 5 |
| Myomectomy-hysteroscopic (n=255; 13%) | 1 | 12 | 32 | 64 | 74 | 50 | 22 | 3 |
| Myomectomy-vaginal (n=7; <1%) | 0 | 1 | 0 | 3 | 0 | 2 | 1 | 0 |
| Laparoscopic radiofrequency ablation (n=12; <1%) | 0 | 0 | 0 | 3 | 2 | 3 | 4 | 0 |
| Endometrial ablation (n=146; 7%) | 0 | 0 | 2 | 22 | 54 | 52 | 16 | 5 |
| Uterine artery embolization (n=125; 6%) | 0 | 0 | 5 | 21 | 28 | 58 | 13 | 8 |
| Magnetic resonance—guided focused ultrasound (n=15; <1%) | 0 | 0 | 1 | 1 | 6 | 6 | 1 | 1 |
| Progestin-releasing intrauterine device (n=0; 0%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |